RCUS SMMT Arcus Biosciences and Summit Therapeutics Enter Into Clinical Trial Collaboration to Evaluate Casdatifan Combined with Ivonescimab
RCUS SMMT Arcus Biosciences and Summit Therapeutics Enter Into Clinical Trial Collaboration to Evaluate Casdatifan Combined with Ivonescimab in Kidney Cancer
Story updates
08:31:22 PM UTC
SquawkNews
SMMT RCUS arcus Biosciences and Summit Therapeutics enter into clinical trial collaboration to evaluate casdatifan combined with ivonescimab in kidney cancer Arcus Biosciences Inc: under terms of agreement, Summit will supply ivonescimab and arcus will conduct and sponsor combination study
08:35:27 PM UTC
SquawkNews
RCUS - Arcus Biosciences and Summit Therapeutics Enter Into Clinical Trial Collaboration to Evaluate Casdatifan Combined with Ivonescimab in Kidney Cancer
SMMT RCUS arcus Biosciences and Summit Therapeutics enter into clinical trial collaboration to evaluate casdatifan combined with ivonescimab in kidney cancer Arcus Biosciences Inc: under terms of agreement, Summit will supply ivonescimab and arcus will conduct and sponsor combination study